Product Information

POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1161 per EA under NDC 00832532210. Its NADAC has been published 385 times since Jul 10, 2019.

FDA first approved this application on Apr 17, 1986. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ TABLET

Potassium Chloride
$0.1161per EA

Strength

600 mg/1

NDC

00832532210

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA019123

FDA Approved

4/17/1986

TE Code

AB2

On Market Since

4/17/1986

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 385 times since Jul 10, 2019, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1161 per EA
All-time high$0.2399 (Jan 15, 2020)
All-time low$0.1020 (Aug 19, 2026)
52-week high$0.1411
52-week low$0.1020
Median price$0.1517
Average price$0.1604
Largest weekly change-39.3% (Apr 17, 2024)
Weeks tracked385
Tracking sinceJul 10, 2019

Price History

1W

+2.0%

1M

+12.9%

3M

+13.8%

6M

-5.6%

1Y

-17.0%

3Y

-13.5%

5Y

-36.1%

All

-44.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1161 per EA (NDC 00832532210), effective Nov 18, 2026.

How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 44.0%. It has been tracked across 385 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?

Since Jul 10, 2019, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1020 (Aug 19, 2026) to a high of $0.2399 (Jan 15, 2020), with a median of $0.1517 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 8 MEQ TABLET?

POTASSIUM CL ER 8 MEQ TABLET (NDC 00832532210) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.